<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-052219</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Bilateral recurrent autoimmune optical neuropathy in childhood</dc:title>
<dc:description xml:lang="en">Clinical case: A ten year-old girl, after a Yersinia    gastroenteritis, developed an optic neuritis in the    left eye. She was not treated and resulted ultimately    in optic atrophy on the affected side. Six months    later a similar episode occurred in the contralateral    eye. On this occasion corticosteroid therapy was    given. During this therapy the neuritis diminished;    however the patient had three relapses, so it was    decided to give her immunosuppressive treatment    with azathioprine and continue this indefinitely.    Discussion: After considering the differential diagnoses    of bilateral recurrent optical neuritis in childhood,    we concluded that it was most likely to have    an autoimmune basis. After considering the benefits    and risks of the long-term treatment, we believe    immunosuppressive therapy is most useful in controlling    the disease allowing corticosteroid therapy    to be reduced (AU)</dc:description>
<dc:creator>Sádaba, LM</dc:creator>
<dc:creator>Heras, H</dc:creator>
<dc:creator>Salinas Alamán, A</dc:creator>
<dc:creator>García-Gómez, P. J</dc:creator>
<dc:creator>Belzunce, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Niña de 10 años, que tras gastroenteritis    por Yersinia debuta con neuritis óptica en ojo    izquierdo. No recibe tratamiento y evoluciona a    atrofia óptica. A los 6 meses presentó un episodio    en el ojo contralateral, instaurándose tratamiento    corticoideo. Durante su disminución progresiva    sufre tres recaídas. Se decide instaurar tratamiento    con inmunosupresores, manteniéndose estable desde    entonces sin efectos secundarios.    Discusión: Tras descartar las múltiples causas de    neuritis óptica bilateral recidivante en una niña, se    concluye que la etiología era autoinmune. Valorando    los beneficios y riesgos del tratamiento con    inmunosupresores creemos que permiten el control    de la enfermedad y el ahorro corticoideo (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;81(10): 607-610, oct. 2006. ilus</dc:source>
<dc:identifier>ibc-052219</dc:identifier>
<dc:title xml:lang="es">Neuropatía óptica autoinmune recidivante bilateral en la infancia</dc:title>
<dc:subject>^d7344^s22073</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d1394^s22073</dc:subject>
<dc:subject>^d27728^s22016</dc:subject>
<dc:subject>^d27729^s22027</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d15407^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>200610</dc:date>
</metadata>
</record>
</ibecs-document>
